GP training trial aims to curb unnecessary antibiotic use

NCT ID NCT06953804

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two ways to help general practitioners (GPs) use antimicrobial stewardship resources when treating respiratory tract infections. One group gets online training and self-audit tools; the other gets face-to-face support. Researchers will track how often GPs use these resources and ask patients for feedback. The goal is to find the most effective way to reduce unnecessary antibiotic prescribing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
antimicrobial stewardship training (online modules, self-audit, podcasts, or face-to-face activities)
What this could lead to
If successful, this could show the best way to help GPs use antimicrobial stewardship resources, potentially reducing unnecessary antibiotic use for respiratory infections.
What could go wrong
This is an implementation study, not a treatment trial. It measures how often doctors use resources, not direct patient outcomes. Results may not apply outside Australia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS (RTI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bond University

    RECRUITING

    Gold Coast, Queensland, 4226, Australia

  • Monash University

    RECRUITING

    Melbourne, Victoria, 3800, Australia

  • University of Tasmania

    RECRUITING

    Hobart, Tasmania, 7005, Australia

  • University of Wollogongong

    RECRUITING

    Wollongong, New South Wales, 2500, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.